Johnson & Johnson's former consumer unit, Kenvue Inc (NYSE: KVUE), reported its first quarterly earnings after being spun off in May. Q2 sales increased 5.4% Y/Y to $4.01 billion, a Y/Y increase of 5.4%, beating the consensus of $3.96 billion. Foreign currency fluctuations negatively impacted net sales by approximately 2.3%. Organic growth increased by 7.7%. Net sales at Kenvue's self-care business, which houses over-the-counter products or nonprescription medicines, jumped 12.2% due to increase